Skip to main content
    N

    NRX Pharmaceuticals Inc (NRXP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.15
    -0.04 (-1.83%)

    Market Cap: $95.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NRX Pharmaceuticals Inc (NRXP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to NRX Pharmaceuticals are Rein Therapeutics (RNTX), RenovoRx (RNXT) and Tenax Therapeutics (TENX). By market cap, NRX Pharmaceuticals ranks 6th of the 13 companies on this page; Rocket Pharmaceuticals (RCKT) is the largest at $256.82M.

    Peer Comparison

    NRXP's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    NRX Pharmaceuticals (NRXP)$95.58MN/A23.8x0.0%N/A0.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    RenovoRx Inc (RNXT)$50.18MN/A16.6x0.0%N/A300.8%0.00%
    Tenax Therapeutics Inc (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Minerva Neurosciences Inc (NERV)$114.62MN/AN/A0.0%N/A0.0%0.00%
    LENZ Therapeutics Inc (LENZ)$129.77MN/A9.7x0.0%N/A-72.9%0.00%
    Nkarta Inc (NKTX)$85.23MN/AN/A0.0%N/A0.0%0.00%
    ProQR Therapeutics BV (PRQR)$199.28MN/A6.1x-228.2%N/A120.4%0.00%
    Rani Therapeutics Holdings Inc (RANI)$60.78MN/A16.3x0.0%N/A893.0%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    Rallybio Corp (RLYB)$88.03MN/A203.1x6177.0%N/A0.0%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Peer median$86.63MN/A16.3x0.0%-131.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to NRX Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    RenovoRx Inc (RNXT)
    RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors.
    RNXT competitors
    Tenax Therapeutics Inc (TENX)
    Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing...
    TENX competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Minerva Neurosciences Inc (NERV)
    Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products...
    NERV competitors
    LENZ Therapeutics Inc (LENZ)
    LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders...
    LENZ competitors
    Nkarta Inc (NKTX)
    Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer.
    NKTX competitors
    ProQR Therapeutics BV (PRQR)
    ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders.
    PRQR competitors
    Rani Therapeutics Holdings Inc (RANI)
    Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology...
    RANI competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    Rallybio Corp (RLYB)
    Rallybio Corp is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases...
    RLYB competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors

    Frequently Asked Questions About NRXP

    Who are NRX Pharmaceuticals' main competitors?

    The companies most similar to NRX Pharmaceuticals include Rein Therapeutics (RNTX), RenovoRx (RNXT), Tenax Therapeutics (TENX), Neumora Therapeutics (NMRA) and Minerva Neurosciences (NERV), listed from the closest match.

    Who is NRX Pharmaceuticals' biggest competitor?

    Rocket Pharmaceuticals (RCKT) is the largest of the similar companies at $256.82M; Rein Therapeutics (RNTX) is the closest match by business profile, size, sector and industry.

    How does NRXP stock compare with its competitors?

    NRXP's P/S is 23.8x against a peer median of 16.3x; its net margin is 0.0% against a peer median of 0.0%.

    Which of NRX Pharmaceuticals' competitors pays a higher dividend?

    NRX Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is NRX Pharmaceuticals bigger than its competitors?

    No. NRX Pharmaceuticals is 6th by market cap among the 13 companies on this page; the largest is Rocket Pharmaceuticals (RCKT) at $256.82M.